awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36153450-1D752DF9-4C78-4533-8058-B331FA046496
Q36153450-1D752DF9-4C78-4533-8058-B331FA046496
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36153450-1D752DF9-4C78-4533-8058-B331FA046496
A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer
P2860
Q36153450-1D752DF9-4C78-4533-8058-B331FA046496
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36153450-1D752DF9-4C78-4533-8058-B331FA046496
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96954479b77fe4bf353b6d4abb0aa30fca0d6b6b
P2860
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.